Pamela S. Douglas
Duke University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Cardiovascular Function and Risk Factors
Strong evidence · 4 supporting papers · latest 2026
Cardiac Imaging and Diagnostics
Strong evidence · 5 supporting papers · latest 2026
HIV-related health complications and treatments
Strong evidence · 3 supporting papers · latest 2026
Viral-associated cancers and disorders
Strong evidence · 1 supporting paper · latest 2026
Cardiovascular Disease and Adiposity
Solid evidence · 2 supporting papers · latest 2026
Coronary Interventions and Diagnostics
Solid evidence · 3 supporting papers · latest 2026
Social Media in Health Education
Solid evidence · 1 supporting paper · latest 2026
Ethics in Clinical Research
Solid evidence · 1 supporting paper · latest 2026
Publications (15)
Prognostic value of pericoronary adipose tissue on ECG-gated non-contrast CT in patients with stable chest pain: insights from the PROMISE trial
2026DOIPMID 42614087
Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis
2026DOIPMID 42699213
Impact of the 2025 ASE Guidelines on the Classification of LV Diastolic Dysfunction in the Community: A Project Baseline Health Study
2026DOIPMID 42131912
Cancer incidence and risk factors among people with HIV in REPRIEVE
2026DOIPMID 42758480
The LV-LA Health Score: A Novel Marker of Integrated Myocardial Structure and Function
2026DOI
Pitavastatin effect on enterocyte injury markers in an ART treated HIV population: Insights from REPRIEVE
2026DOIPMID 42357945
CCTA characterization of coronary atherosclerosis diffuseness and focality using FFR-CT and plaque burden: results from the PRECISE trial
2026DOIPMID 42659899
Messaging Modality and Content for Recruitment of Research Participants
2026DOIPMID 42172031
Absence of significant coronary artery disease does not eliminate smoking-related cardiovascular risk: insights from the PROMISE trial
2026DOI
Association Between Predicting Risk of Cardiovascular Disease Events (PREVENT) Risk Scores and Subclinical Cardiovascular Disease: Insights From the Project Baseline Health Study
2026DOIPMID 42216265
Design and Rationale of the pERSonalized cardIovascuLar dIsease prEvention, treatmeNt, and CarE (RESILIENCE) study
2026DOIPMID 42248410
Reply
2026DOIPMID 42362097
A validated, modifiable proteomic score from the EXSCEL trial predicts cardiovascular events in diabetes
2026DOIPMID 42390946
Proteomic Signatures of High-Risk Coronary Plaque Features and Incident Events
2026DOIPMID 42485930
Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial
2026DOIPMID 42431097
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Duke University
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27